Sponsors
Show: November 18, 2012:
- How do traditional and social media converge to help those with rare diseases?
- What happens when a leading medical institution excludes a new drug from its treatment panel?
- What are the long term effects of ADHD?
- What happens when patients don’t follow doctors’ orders?
- How do you know if it is time to reach out for help with addiction?
- What makes your stomach turn?
- What do "mundane" behaviors accomplish?
- When should doctors retire?
- View all topics for the week
Sound Medicine is brought to you by:
What happens when a leading medical institution excludes a new drug from its treatment panel?
views 297
Air date: November 18, 2012
Host: Eric Metcalf
Interview: Aaron Carroll M.D., M.S., Director for the Center of Health Policy and Professionalism Research, Indiana University School of Medicine and associate professor of pediatrics.
After Memorial Sloan-Kettering Cancer Center decided it would not use a drug that cost twice that of a comparable one with the same efficacy, the manufacturer decided it would reduce its cost by half. Aaron Carroll, M.D., M.S., talks about the situation and the impact it could have on the health care arena. Carroll is director for the Center of Health Policy and Professionalism Research and associate professor at the IU School of Medicine.
Additional Resources:
- Check out the New York Times article that inspired this discussion.
